Streetbeat News

Earnings

PWSC

PowerSchool Holdings (NYSE:PWSC) is scheduled to release its quarterly earnings report on February 26, 2024, with analysts estimating an EPS of $0.21. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter resulting in a 1.55% increase after beating EPS estimates. Shares are currently trading at $23.34, marking a 2.26% increase over the last 52 weeks. Investors are looking forward to not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 3:01 pm

MRVL

Recent unusual options activity in Marvell Tech (NASDAQ:MRVL) has been observed, with a bearish sentiment prevailing among high-rolling investors. Benzinga's options scanner identified 8 trades, showing a split sentiment with 37% bullish and 62% bearish. The focus is on a price band between $67.0 and $80.0. The most significant options trades include both calls and puts, with a bearish sentiment on calls and a single bearish put. Marvell Technology, a leading fabless chip designer, currently trades at $69.74, slightly down with a potential overbought RSI. The next earnings report is due in 13 days.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 3:01 pm

SBAC

SBA Communications (NASDAQ:SBAC) is scheduled to release its quarterly earnings report on February 26, 2024, with analysts expecting an EPS of $1.37. The focus will be on whether SBAC beats this estimate and provides positive guidance for the next quarter. Historical data shows mixed reactions to past earnings, with the stock price fluctuating based on performance and guidance. Shares have declined 18.1% over the last year, indicating potential investor concern ahead of the earnings announcement.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 3:01 pm

TMDX

TransMedics Gr (NASDAQ:TMDX) is scheduled to release its quarterly earnings report on February 26, 2024, with an expected EPS of $-0.03. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historically, TransMedics has had a mixed performance in beating EPS estimates, with significant share price movements following the earnings announcements. The stock has seen a 9.52% increase over the last 52 weeks, trading at $84.81 as of February 22.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 3:01 pm

ADUS

Addus HomeCare (NASDAQ:ADUS) is scheduled to release its quarterly earnings report on February 26, 2024, with analysts estimating an EPS of $1.17. Historical data shows mixed reactions to past earnings, with the last quarter's beat resulting in a 5.16% share price drop. Over the last year, ADUS shares have declined by 15.03%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 3:00 pm

SGRY

Surgery Partners (NASDAQ:SGRY) is scheduled to release its quarterly earnings report on February 26, 2024, with analysts estimating an EPS of $0.38. The company's past earnings performance shows a mix of beats and misses, with the share price reacting variably. Shares are currently trading at $32.86, down 3.72% over the last 52 weeks. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 3:00 pm

MRNA

Analyst ratings for Moderna (NASDAQ:MRNA) have varied over the last quarter, with recent updates showing a mix of 'Hold' and 'Outperform' ratings. The average 12-month price target has risen to $106.0, a 21.14% increase from the previous $87.50, indicating a positive outlook. Moderna's financials reveal challenges, including a -44.5% revenue decline and below-average net margin and ROE. Despite this, its mRNA technology and diverse clinical trial programs position it as a key player in biotech.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 3:00 pm

AU

AngloGold Ashanti reported its FY 2023 sales at $4.48 billion, marking an increase from the previous year's $4.39 billion.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 2:58 pm

SQ

Block (NYSE:SQ), also known as Square, saw its stock surge over 20% following its Q4 earnings report, which included a revenue surprise of 1.28% but an EPS miss by 23.73%. CEO Jack Dorsey highlighted cost reductions and a focus on growth. JPMorgan analyst Tien-tsin Huang maintains an Overweight rating on SQ with a $90 price target, citing strong Cash App momentum and potential from expanding banking services. Block's FY24 outlook anticipates over 15% gross profit growth, with innovations like a 'pay-as-you-go' model and bundled restaurant offerings seen as additional growth catalysts.

Portfolio Pulse from Surbhi Jain

February 23, 2024 | 2:55 pm

GLCNF

TECK

Teck Resources Ltd (NYSE:TECK) exceeded Q4 2023 earnings estimates with record copper production and strong steelmaking coal sales, driven by higher copper prices. The company announced progress on the sale of its coal unit to Glencore PLC (OTCPK: GLCNF) for $9 billion, expected to close by Q3 2024. Teck also declared a dividend and authorized a stock buyback of up to $500 million.

Portfolio Pulse from Stjepan Kalinic

February 23, 2024 | 2:54 pm